As another approach for treating hyperammonemia, bumetanide, an inhibitor of the Na+-K+-2Cl− cotransporter, could be used for alleviating the clinical and electrophysiological features of neurotoxicity due to excessive ammonia, which hyperactivates the Na+-K+-2Cl− cotransporter [85]. Here, SLC12A1 is linked to Hyperammonemia.